Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy-Reference-Cited by-同舟云学术

Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy

Published:2013-11-16 Issue:6 Volume:98 Page:702-707
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Yanagimachi Masakatsu,Goto Hiroaki,Kaneko Tetsuji,Naruto Takuya,Sasaki Koji,Takeuchi Masanobu,Tanoshima Reo,Kato Hiromi,Yokosuka Tomoko,Kajiwara Ryosuke,Fujii Hisaki,Tanaka Fumiko,Goto Shoko,Takahashi Hiroyuki,Mori Masaaki,Kai Sumio,Yokota Shumpei

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-013-1464-z.pdf

Reference28 articles.

1. Allegra CJ. Antifolates. In: Chabner BA, Collins JM, editors. Cancer chemotherapy: principles and practice. Philadelphia: Lippincott Company; 1990. p. 110–53.

2. Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol. 2007;19:341–6.

3. Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med. 1983;309:1094–104.

4. Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008;9:257–68.

5. Schmiegelow K. Advances in individual prediction of methotrexate toxicity: a review. Br J Haematol. 2009;146:489–503.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for acute kidney injury after high-dose methotrexate therapy: a single-center study and narrative review;European Journal of Clinical Pharmacology;2023-04-15

2. Impact of pre-hydration duration on high-dose methotrexate induced nephrotoxicity in childhood acute lymphoblastic leukaemia in resource constraint centers: a randomized crossover study;Cancer Chemotherapy and Pharmacology;2023-03-23

3. Analysis of Pathogenesis of Drug-associated Neurotoxicity by Proteomics and Pharmacogenetics;Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics;2023-01-31

4. Extracorporeal Treatment for Methotrexate Poisoning;Clinical Journal of the American Society of Nephrology;2022-04

5. The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2021-10-21